1
Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
Condition(s):Solid CarcinomaLast Updated:February 17, 2020Recruiting
Immuno-oncology: 195 Clinical Trials, Page 1 of 20
Hide Studies Not Open or Pending
2
Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination
Condition(s):Advanced Renal Cell Carcinoma (aRCC)Last Updated:July 1, 2022Completed
3
Optimization of the Patient Care Pathway in Immuno-oncology
Condition(s):MelanomaLast Updated:February 24, 2021Completed
4
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era
Condition(s):Kidney Cancer; Clear Cell Renal Cell Carcinoma Metastatic; Synchronous NeoplasmLast Updated:March 3, 2023Recruiting
5
Immuno-Oncology Database and Bioregistry
Condition(s):Malignancy; Immune System Diseases; Autoimmune DiseasesLast Updated:February 15, 2023Recruiting
6
Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)
Condition(s):Head and Neck Cancer; Advanced Cancer; Metastatic Cancer; HNSCC; Squamous Cell CarcinomaLast Updated:May 19, 2022Completed
7
Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
Condition(s):Multiple Myeloma; Relapsed Refractory Multiple MyelomaLast Updated:September 10, 2021Recruiting
8
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance
Condition(s):Non-small Cell Lung CancerLast Updated:September 22, 2022Recruiting
9
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling)
Condition(s):Non-small Cell Lung Cancer PatientsLast Updated:September 22, 2022Recruiting
10
Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
Condition(s):Renal Cell CarcinomaLast Updated:May 9, 2022Recruiting